Bayer- General View About Contraceptive Methods
SEPTEMBER 27 2012: PORT OF SPAIN, TRINIDAD AND TOBAGO - The following shows a general view about present contraceptive methods and the new developments.
1 . Micropill 24/4
2. Micropill 21/7
3. Micropill with natural estrogen
4. Intra-uterine system
5. Hormonal implant
6. Condom
7. Cervical cap / diaphragm
8. The rhythm
9. Chemical contraceptives
10. Mini pill
11. Three-month injection
12. Hormonal ring
13. Hormonal patch
14. Intrauterine device
Ø New developments
o New chemical entities
Ø New progestins
o New progestins in with new clinical benefits
Ø New estrogen instead of ethinyl estradiol
o New ways of application
Ø Self-injectables and wafers
Ø New regimes
o 24/4
o 26/2
o More flexible periods
Ø Additional non contraceptive benefits
o Prolonged and heavy menstrual bleeding
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer
HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31 , 2011) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.
Find more information at www.bayerpharma.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.